BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 24549285)

  • 1. XTEN-annexin A5: XTEN allows complete expression of long-circulating protein-based imaging probes as recombinant alternative to PEGylation.
    Haeckel A; Appler F; Figge L; Kratz H; Lukas M; Michel R; Schnorr J; Zille M; Hamm B; Schellenberger E
    J Nucl Med; 2014 Mar; 55(3):508-14. PubMed ID: 24549285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-circulating XTEN864-annexin A5 fusion protein for phosphatidylserine-related therapeutic applications.
    Haeckel A; Ascher L; Beindorff N; Prasad S; Garczyńska K; Guo J; Schellenberger E
    Apoptosis; 2021 Oct; 26(9-10):534-547. PubMed ID: 34405304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
    Däpp S; García Garayoa E; Maes V; Brans L; Tourwé DA; Müller C; Schibli R
    Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XTEN as Biological Alternative to PEGylation Allows Complete Expression of a Protease-Activatable Killin-Based Cytostatic.
    Haeckel A; Appler F; Ariza de Schellenberger A; Schellenberger E
    PLoS One; 2016; 11(6):e0157193. PubMed ID: 27295081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specifically 11C-labeled Sel-tagged annexin A5 and a size-matched control for dynamic in vivo PET imaging of protein distribution in tissues prior to and after induced cell death.
    Cheng Q; Lu L; Grafström J; Olofsson MH; Thorell JO; Samén E; Johansson K; Ahlzén HS; Linder S; Arnér ES; Stone-Elander S
    Biochim Biophys Acta; 2013 Mar; 1830(3):2562-73. PubMed ID: 23262140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved radiolabeling of PEGylated protein: PEGylated annexin V for noninvasive imaging of tumor apoptosis.
    Wen X; Wu QP; Ke S; Wallace S; Charnsangavej C; Huang P; Liang D; Chow D; Li C
    Cancer Biother Radiopharm; 2003 Oct; 18(5):819-27. PubMed ID: 14629830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extension of in vivo half-life of biologically active peptides via chemical conjugation to XTEN protein polymer.
    Podust VN; Sim BC; Kothari D; Henthorn L; Gu C; Wang CW; McLaughlin B; Schellenberger V
    Protein Eng Des Sel; 2013 Nov; 26(11):743-53. PubMed ID: 24133142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion of a recombinant antibody fragment with a homo-amino-acid polymer: effects on biophysical properties and prolonged plasma half-life.
    Schlapschy M; Theobald I; Mack H; Schottelius M; Wester HJ; Skerra A
    Protein Eng Des Sel; 2007 Jun; 20(6):273-84. PubMed ID: 17595342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific 68Ga-labeled Annexin A5 as a PET imaging agent for apoptosis.
    Bauwens M; De Saint-Hubert M; Devos E; Deckers N; Reutelingsperger C; Mortelmans L; Himmelreich U; Mottaghy FM; Verbruggen A
    Nucl Med Biol; 2011 Apr; 38(3):381-92. PubMed ID: 21492787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered annexin A5 variants have impaired cell entry for molecular imaging of apoptosis using pretargeting strategies.
    Ungethüm L; Kenis H; Nicolaes GA; Autin L; Stoilova-McPhie S; Reutelingsperger CP
    J Biol Chem; 2011 Jan; 286(3):1903-10. PubMed ID: 21078669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold fluorescent annexin A5 as a novel apoptosis detection tool.
    Kurschus FC; Pal PP; Bäumler P; Jenne DE; Wiltschi B; Budisa N
    Cytometry A; 2009 Jul; 75(7):626-33. PubMed ID: 19437539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic.
    Bell SJ; Fam CM; Chlipala EA; Carlson SJ; Lee JI; Rosendahl MS; Doherty DH; Cox GN
    Bioconjug Chem; 2008 Jan; 19(1):299-305. PubMed ID: 18020402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Past, present, and future of annexin A5: from protein discovery to clinical applications.
    Boersma HH; Kietselaer BL; Stolk LM; Bennaghmouch A; Hofstra L; Narula J; Heidendal GA; Reutelingsperger CP
    J Nucl Med; 2005 Dec; 46(12):2035-50. PubMed ID: 16330568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells.
    Vangestel C; Peeters M; Oltenfreiter R; D'Asseler Y; Staelens S; Van Steenkiste M; Philippé J; Kusters D; Reutelingsperger C; Van Damme N; Van de Wiele C
    Nucl Med Biol; 2010 Nov; 37(8):965-75. PubMed ID: 21055628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and application of [18F]FDG-maleimidehexyloxime ([18F]FDG-MHO): a [18F]FDG-based prosthetic group for the chemoselective 18F-labeling of peptides and proteins.
    Wuest F; Berndt M; Bergmann R; van den Hoff J; Pietzsch J
    Bioconjug Chem; 2008 Jun; 19(6):1202-10. PubMed ID: 18481886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary in vivo evaluation of a novel 99mTc-labeled HYNIC-cys-annexin A5 as an apoptosis imaging agent.
    Fonge H; de Saint Hubert M; Vunckx K; Rattat D; Nuyts J; Bormans G; Ni Y; Reutelingsperger C; Verbruggen A
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3794-8. PubMed ID: 18524580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivalent antiviral XTEN-peptide conjugates with long in vivo half-life and enhanced solubility.
    Ding S; Song M; Sim BC; Gu C; Podust VN; Wang CW; McLaughlin B; Shah TP; Lax R; Gast R; Sharan R; Vasek A; Hartman MA; Deniston C; Srinivas P; Schellenberger V
    Bioconjug Chem; 2014 Jul; 25(7):1351-9. PubMed ID: 24932887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between human pharmacokinetics and imaging properties of two conjugation methods for 99mTc-annexin A5.
    Boersma HH; Liem IH; Kemerink GJ; Thimister PW; Hofstra L; Stolk LM; van Heerde WL; Pakbiers MT; Janssen D; Beysens AJ; Reutelingsperger CP; Heidendal GA
    Br J Radiol; 2003 Aug; 76(908):553-60. PubMed ID: 12893698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V.
    Ke S; Wen X; Wu QP; Wallace S; Charnsangavej C; Stachowiak AM; Stephens CL; Abbruzzese JL; Podoloff DA; Li C
    J Nucl Med; 2004 Jan; 45(1):108-15. PubMed ID: 14734682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linking proteins with anionic nanoparticles via protamine: ultrasmall protein-coupled probes for magnetic resonance imaging of apoptosis.
    Schellenberger E; Schnorr J; Reutelingsperger C; Ungethüm L; Meyer W; Taupitz M; Hamm B
    Small; 2008 Feb; 4(2):225-30. PubMed ID: 18203233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.